ATB Capital Markets budget Canada Canada/International Canadian excise taxes Cannabis Council of Canada cannabis taxes cultivation excise tax finance Frederico Gomes Great Gardener Farms Kirk Tousaw manufacturing marijuana taxes Pablo Zuanic Paul McCarthy recreational taxes Tilray Brands

Canada’s cannabis industry prays for tax reform in federal budget

Canada’s Liberal government unveils its 2024 budget on Tuesday, and the country’s cannabis industry wants one thing above all: relief from a heavy excise-tax burden.
Canada’s cannabis industry prays for tax reform in federal budget is a post from…

ATB Capital Markets Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry Extraction News Cannabis Industry Science News Cronos David Kideckel Europe Cannabis Industry & Marijuana Business News farming Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Marijuana Cultivation News Nextleaf Solutions organigram Shoppers Drug Mart Tilray United States Cannabis Industry & Marijuana Business News

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…

ATB Capital Markets Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry Extraction News Cannabis Industry Science News Cronos David Kideckel Europe Cannabis Industry & Marijuana Business News farming Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Marijuana Cultivation News Nextleaf Solutions organigram Shoppers Drug Mart Tilray United States Cannabis Industry & Marijuana Business News

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…